Symposium VV: Nanomedicine for Molecular Imaging and Therapy

2012 MRS Spring Meeting logo

Nanomedicine for Molecular Imaging and Therapy

Theranostics was initially defined as thera(py) + (diag)nostics, a term used to link a diagnostic to therapeutic, which is expected to improve patient outcomes, including safety, with a more personalized approach to medicine.  Theranostic nanomedicine has evolved into an integrated nano-particle platform that contains both the therapy and imaging components.  The nanoparticles may carry chemo, radio, and/or gene therapeutics.  The same biocompatible nanomaterial with the intrinsic physicochemical properties or appropriate labels would ideally allow us to diagnose disease, depict the pharmacokinetics of the nanoparticles, assess the release of the drugs, and evaluate the treatment efficacy.  This symposium aims to give a comprehensive review of the state-of-the-art of nanomedicine for molecular imaging and molecular therapy applications and provide future perspectives of translating the novel concepts and nanoconstructs into clinic to improve public health.

Session topics will include:

  • Basics of nanoparticle synthesis and characterization
  • Pharmacokinetics and pharmacodynamics of nanoparticles
  • How molecular imaging can accelerate the development and screening of nanotherapy
  • Nanotherapeutics in cancer, cardiology, and CNS disorders
  • Different theranostic platforms
  • Clinical translation of nanomedicine

Invited speakers include:

James Baker (Univ. of Michigan), Mostafa El-Sayed (Georgia Inst. of Technology), Mauro Ferrari (Methodist Hospital Research Inst.), Jean Fréchet (Univ. of California, Berkeley), Taeghwan Hyeon (Seoul National Univ., Korea), Kazunori Kataoka (Univ. of Tokyo, Japan), Chad Mirkin (Northwestern Univ.), Andre Nel (Univ. of California, Los Angeles), Francis Szoka (Univ. of California, San Francisco), Mark Tracy (Alnylam Pharmaceuticals, Inc.), Jackie Y. Ying (Inst. of Bioengineering and Nanotechnology, Singapore), Gang Zheng (Univ. of Toronto, Canada), Jeffrey Zink (Univ. of California, Los Angeles).

Symposium Organizers

Xiaoyuan (Shawn) Chen
National Institute of Biomedical Imaging and Bioengineering
National Institutes of Health
1C22, 31 Center Dr.
Bethesda, MD 20892-2281
Tel 301-451-4246, Fax 301-480-067
shawn.chen@nih.gov 

Jinwoo Cheon
Yonsei University
Dept. of Chemistry
50 Yonsei-ro, Seodaemun-gu
Seoul 120-749, Korea
Tel 82-2-2123-5631, Fax 82-2-364-7050
jcheon@yonsei.ac.kr 

Mansoor Amiji
Northeastern University
Dept. of Pharmaceutical Sciences
360 Huntington Ave.
Boston, MA 02115
Tel 617-373-3137, Fax 617-373-8886
m.amiji@neu.edu 

Shuming Nie
Emory University
Dept. of Biomedical Engineering,
Ste. 2007, 101 Woodruff Circle
Atlanta, GA 30322
Tel 404-712-8595, Fax 404-727-3567
snie@emory.edu 

AdAd Back To Top
Ad